Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03390790 · ClinicalTrials.gov registry record · Phase 4
Lidocaine for Pain After Urodynamic Testing
A Phase 4 study, sponsored by Atlantic Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 134
- Enrollment target
NCT03390790 is a Phase 4 study that has completed, run by Atlantic Health System. The registered enrollment target is 134 participants.
The verdict
NCT03390790, a Phase 4 study, has completed, sponsored by Atlantic Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 134 participants
- Enrollment target
Study Summary
Urodynamic testing can be associated with mild discomfort, particularly at the time of insertion, repositioning, and removal of the bladder catheter (a tube inserted into the bladder via the urethra). Few studies have investigated ways to improve patient comfort during this procedure. In this study, the investigators want to see if applying external lidocaine (a numbing gel) prior to the procedure can help to minimize patient discomfort.
Interventions
- DRUG Lidocaine gel 2%
- OTHER Standard lubricant gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2018-01-25 |
| Est. Completion | 2019-03-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03390790
The ClinicalTrials.gov registry entry for NCT03390790 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Atlantic Health System, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lidocaine gel 2% is the first listed.
NCT03390790 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03390790 about?
NCT03390790 is a clinical study titled "Lidocaine for Pain After Urodynamic Testing". Urodynamic testing can be associated with mild discomfort, particularly at the time of insertion, repositioning, and removal of the bladder catheter (a tube inserted into the bladder via the urethra). Few studies have investigated ways to improve patient comfort during this procedure. In this study,...
What is the current status of trial NCT03390790?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 134 participants. The study started on 2018-01-25. Estimated completion is 2019-03-29.
What interventions are being tested in trial NCT03390790?
The interventions under investigation include: Lidocaine gel 2% (DRUG), Standard lubricant gel (OTHER).
Who is sponsoring clinical trial NCT03390790?
This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.